News
-
CW on Gruen
Friday | May 18 2018THE ABC's Gruen media and marketing show this week featured a segment on Chemist Warehouse, describing the company as a "media empire" with an annual marketing budget of $100 million.
-
Dispensary Corner
Friday | May 18 2018
18 May 18AMERICAN confectionery maker Hershey manufactures products classified as a "sometimes" food.
-
Sigma sees branded growth
Thursday | May 17 2018SIGMA Healthcare ceo Mark Hooper yesterday confirmed the company was "starting to see a return to growth in our brand member pipeline," but said general trading conditions have continued to be challenging in the last quarter.
-
TGA warns on illicit CBD
Thursday | May 17 2018THE Therapeutic Goods Administration has issued an alert about "false and misleading claims" being made by some companies supplying cannabidiol (CBD) products in Australia.
-
Testimonials tool
Thursday | May 17 2018THE Australian Health Practitioner Regulation Agency has launched a new tool to help advertisers understand their obligations about using testimonials and reviews to promote regulated health services.
-
Pfizer epoetin ticked
Thursday | May 17 2018THE US Food and Drug Administration (FDA) on Tues approved the first biosimilar to Amgen's blockbuster Epogen/Procrit (epoetin alfa), bringing the total number of biosimilars approved by the agency to 10.
-
CP2025 scenarios
Thursday | May 17 2018THE Pharmacy Guild's Community Pharmacy 2025 project is now moving into its second and final phase, which will focus on the development of practical action plans to enable pharmacies and the broader sector to realise the benefit of potential growth paths.
-
Ibuprofen not for UTI
Thursday | May 17 2018IBUPROFEN, given instead of antibiotics to women with uncomplicated urinary tract infection (cystitis), leads to longer duration of symptoms and more serious adverse events related to the spread of the primary infection, according to a new study in PLOS Medicine from the University of Oslo, Norway - CLICK HERE.
-
New PBS antiepileptic
Thursday | May 17 2018AN ANTIEPILEPTIC add-on treatment shown to be effective without the need to titrate for tolerability, is now PBS funded.
-
